Light therapy for glioblastoma brain tumors
Part of Cancer clinical trials.
This trial tests a light-based treatment for a type of brain tumor called glioblastoma. The treatment uses a special light to target and destroy tumor cells, which might help people whose tumors have come back or are in multiple spots.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with glioblastoma, a type of brain tumor.
- Your tumor is either new, has come back after treatment, or appears in multiple areas.
- You are not allergic to photosensitizers (drugs that make cells sensitive to light).
- You do not have severe bleeding problems, serious heart or blood vessel disease, or multiple organ failure.
- You are not pregnant (the light-sensitive drug used is not safe during pregnancy).
- You are willing to sign a consent form to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a light-activated therapy (radiodynamic therapy) using a special medicine to help treat a brain tumor that has come back after prior treatment. It may be offered after doctors decide you need further radiation for your recurrence.
This trial tests a new light-based treatment that is given alongside standard chemotherapy and radiation for people with a type of brain tumor called 'butterfly glioblastoma'. The goal is to see if adding this therapy can improve outcomes for patients with this challenging condition.
This trial tests a new approach that uses a light-sensitive drug and low-intensity ultrasound to make standard chemotherapy more effective for glioblastoma. If you have completed initial treatment with radiation and temozolomide without the tumor growing, you may be eligible.
This trial combines a new therapy (sonodynamic therapy) with standard radiation and chemotherapy for glioblastoma. It aims to see if this approach is safe and how well it works for people who have just been diagnosed and had surgery.
This trial tests a cancer-immunotherapy medicine (an anti–PD-1 antibody, similar to pembrolizumab) combined with precisely targeted radiation to treat glioblastoma that has come back or progressed. It may help your immune system recognize and attack the tumor while the radiation targets the cancer.
This trial tests a special radiation boost that targets low-oxygen areas of the brain tumor during standard radiation therapy. It may help control the tumor better for people with newly diagnosed or recurrent glioblastoma.
Hear when a new Glioblastoma Multiforme (GBM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.